ArticleTranslational lung cancer research2022

Tolerability, safety, and preliminary antitumor activity of fuzuloparib in combination with SHR-1316 in patients with relapsed small cell lung cancer: a multicenter, open-label, two-stage, phase Ib trial.

Yanjun Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.